Pre-surgery assessment for patient-related outcome after an extensive urological tumorsurgery, validation of the Erlangen-Index

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032836

Enrollment

380

Registered

2023-10-16

Start date

2020-02-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61 C68.8 C64

Interventions

Group 1: -prospective noninterventional validation study -Group: 1. Cancer of the urogenital tract (prostate, kidneys, bladder) 2. Age of the Patients >/= 70 years - Pre-surgery assessment, approx. 6

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age >=65 - Extensive urological/urooncoligical surgery (prostatectomy, cystectomy, nephrectomy, revision, laparotomy, radioguided surgery) - Patient or his relatives speak german - Signed Consent of the patient regarding the study-related data collection up to 6 months after the initial assessment

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Functional outcome after 30 days Functional outcome after 180 days Complications (during the hospital-stay) Mortality rate after 180 days	—

Secondary

Measure	Time frame
Validation of the Erlangen-Index	—

Countries

Austria, Germany

Contacts

Public ContactLukas Koneval

Klinik und Poliklinik für Urologie und Kinderurologie

lukas_koneval@yahoo.de+491734564756

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026